Phase II Gemcitabine + Fractionated Stereotactic Radiotherapy for Unresectable Pancreatic Adenocarcinoma
Status:
Completed
Trial end date:
2015-10-01
Target enrollment:
Participant gender:
Summary
This multi-institutional trial aims to evaluate the potential benefit and side effects of
adding fractionated stereotactic body radiotherapy/surgery (SBRT) before and after
chemotherapy with gemcitabine for locally advanced pancreatic cancer.